Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Advent Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Advent Capital Management
from 13F filings
Historical chart of Advent Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Advent Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Advent Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $12M | 8.4M | 1.41 |
| 2025-06-30 | $10M | 8.8M | 1.14 |
| 2025-03-31 | $14M | 11M | 1.28 |
| 2024-12-31 | $45M | 41M | 1.08 |
| 2024-09-30 | $137k | 115k | 1.19 |
| 2024-06-30 | $26M | 23M | 1.12 |
| 2024-03-31 | $49M | 50M | 0.98 |
| 2023-12-31 | $52M | 56M | 0.93 |
| 2023-09-30 | $70M | 74M | 0.94 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1